S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20

Galliford Try Share Forecast, Price & News

GBX 167
-10.00 (-5.65%)
(As of 11/26/2021 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
798,066 shs
Average Volume
342,689 shs
Market Capitalization
£185.46 million
P/E Ratio
Dividend Yield
30 days | 90 days | 365 days | Advanced Chart
Receive GFRD News and Ratings via Email

Sign-up to receive the latest news and ratings for Galliford Try and its competitors with MarketBeat's FREE daily newsletter.

Galliford Try logo

About Galliford Try

Galliford Try Holdings PLC, together with its subsidiaries, operates in the construction business in the United Kingdom. The company's Building division works with private and public sector clients in health, education, and defense. Its Infrastructure division carries out civil engineering projects in the highways and environment sectors. The company's PPP Investments division delivers various building and infrastructure projects through public-private partnerships and co-development opportunities. Its Facilities Management division provides services for buildings. Galliford Try Holdings PLC was incorporated in 2019 and is based in Uxbridge, the United Kingdom.


See More Headlines

Industry, Sector and Symbol

Residential Construction
Year Founded

Sales & Book Value

Annual Sales
£1.12 billion
Cash Flow
GBX 186.76 per share
Book Value
GBX 122.70 per share


Pretax Margin




Free Float
Market Cap
£185.46 million
Not Optionable

Company Calendar

Last Earnings
Dividend Payable


Overall MarketRank

1.99 out of 5 stars

Analyst Opinion: 3.5Community Rank: 4.8Dividend Strength: 1.7Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Galliford Try (LON:GFRD) Frequently Asked Questions

Is Galliford Try a buy right now?

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Galliford Try in the last twelve months. There are currently 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Galliford Try stock.
View analyst ratings for Galliford Try
or view top-rated stocks.

How has Galliford Try's stock been impacted by COVID-19?

Galliford Try's stock was trading at GBX 141.52 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, GFRD stock has increased by 18.0% and is now trading at GBX 167.
View which stocks have been most impacted by COVID-19

How were Galliford Try's earnings last quarter?

Galliford Try Holdings PLC (LON:GFRD) announced its quarterly earnings results on Wednesday, September, 16th. The company reported ($47.70) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($49.90) by $2.20.
View Galliford Try's earnings history

How often does Galliford Try pay dividends? What is the dividend yield for Galliford Try?

Galliford Try announced a dividend on Thursday, September 16th. Stockholders of record on Thursday, November 11th will be given a dividend of GBX 3.50 per share on Friday, December 10th. This represents a yield of 1.96%. The ex-dividend date is Thursday, November 11th. This is a positive change from Galliford Try's previous dividend of GBX 1.20. The official announcement can be seen at this link.
View Galliford Try's dividend history

Is Galliford Try a good dividend stock?

Galliford Try pays an annual dividend of GBX 0.01 per share and currently has a dividend yield of 2.66%. The dividend payout ratio of Galliford Try is 0.18%. This payout ratio is at a healthy, sustainable level, below 75%.
View Galliford Try's dividend history.

What price target have analysts set for GFRD?

3 Wall Street analysts have issued twelve-month price objectives for Galliford Try's stock. Their forecasts range from GBX 230 to GBX 270. On average, they expect Galliford Try's share price to reach GBX 243.33 in the next twelve months. This suggests a possible upside of 45.7% from the stock's current price.
View analysts' price targets for Galliford Try
or view top-rated stocks among Wall Street analysts.

Who are Galliford Try's key executives?

Galliford Try's management team includes the following people:
  • Mr. Bill Hocking, CEO & Exec. Director (Age 56, Pay $535.92k)
  • Mr. Andrew Duxbury, Fin. Director & Director (Age 46, Pay $640k)
  • Mr. Kevin S. Corbett CEng, MICE, MIStructE, Gen. Counsel, Company Sec. & Member of Exec. Board (Age 61)
  • Mr. Ian Jubb, MD of Building & Member of Exec. Board (Age 56)
  • Mr. Mark Baxter, MD of Investments & Specialist Services and Member of the Exec. Board (Age 49)
  • Ms. Vikki Skene, HR Director & Member of Exec. Board (Age 33)

What other stocks do shareholders of Galliford Try own?

What is Galliford Try's stock symbol?

Galliford Try trades on the London Stock Exchange (LON) under the ticker symbol "GFRD."

How do I buy shares of Galliford Try?

Shares of GFRD and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is Galliford Try's stock price today?

One share of GFRD stock can currently be purchased for approximately GBX 167.

How much money does Galliford Try make?

Galliford Try has a market capitalization of £185.46 million and generates £1.12 billion in revenue each year.

How many employees does Galliford Try have?

Galliford Try employs 2,944 workers across the globe.

What is Galliford Try's official website?

The official website for Galliford Try is www.gallifordtry.co.uk.

Where are Galliford Try's headquarters?

How can I contact Galliford Try?

Galliford Try's mailing address is Cowley Business Park, Cowley, UXBRIDGE, UB8 2AL, United Kingdom. The company can be reached via phone at +44-1895-855001.

This page was last updated on 11/27/2021 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.